Breaking News, Financial News

Financial Report: BASi

Revenues down 17%

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BASi 2Q Revenues: $7.0 million (-17%) 2Q Loss: $1.9 million (Earnings were $483,000 2Q11) YTD Revenues: $14.5 million (-12%) YTD Loss: $3.4 million (Earnings were $793,000 YTD11) Comments: Service revenue was $5.3 million (-18%). Product revenue was $1.7 million (-15%). Results include restructuring charges of $64,000. In addition to the restructuring of its bioanalytical lab operations, the company plans to reduce operating costs at its West Lafayette and Evansville facilities for a saving...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters